METRONIDAZOLE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. (Chemical Entities of Biological Interest Ontology, CHEBI_6909)
External Link https://dgidb.org/results?searchType=drug&searchTerms=METRONIDAZOLE
Similar Terms
Downloads & Tools

Genes

4 interacting proteins for the METRONIDAZOLE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
TSPO translocator protein (18kDa) 0.715297
IL6 interleukin 6 0.433869
ALDH1A1 aldehyde dehydrogenase 1 family, member A1 0.0341057
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.0298713